Penn Mutual Asset Management - SUPERNUS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Penn Mutual Asset Management ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$677,018
+2.1%
675,0000.0%0.64%
-13.2%
Q4 2022$663,188
+0.9%
675,0000.0%0.74%
-14.0%
Q3 2022$657,000
+0.2%
675,0000.0%0.86%
-2.7%
Q2 2022$656,000
-1.2%
675,0000.0%0.88%
+14.8%
Q1 2022$664,000
-0.2%
675,000
+99900.0%
0.77%
+8.0%
Q4 2021$665,000
-1.0%
6750.0%0.71%
-32.9%
Q3 2021$672,000
+0.9%
6750.0%1.06%
+27.8%
Q2 2021$666,000
+2.3%
675
-99.9%
0.83%
+13.2%
Q1 2021$651,000
+1.7%
675,0000.0%0.74%
+30.1%
Q4 2020$640,000
+29.8%
675,000
+25.0%
0.56%
-18.8%
Q3 2020$493,000540,0000.70%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Opti Capital Management, LP 45,402,000$45,147,0003.42%
Ayrton Capital LLC 2,000,000$1,982,0001.87%
Radcliffe Capital Management, L.P. 69,010,000$68,018,0001.78%
TENOR CAPITAL MANAGEMENT Co., L.P. 74,027,000$73,675,0001.54%
DeepCurrents Investment Group LLC 33,182,000$32,736,0001.02%
Penn Mutual Asset Management 675$665,0000.71%
SHENKMAN CAPITAL MANAGEMENT INC 7,897,000$7,533,0000.51%
OAKTREE CAPITAL MANAGEMENT LP 19,901,000$19,714,0000.22%
WOLVERINE ASSET MANAGEMENT LLC 9,940,000$9,858,0000.09%
Jefferies Group LLC 12,740,000$12,658,2850.07%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders